MedTrace Logo

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

NCT00898092 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 735

Last updated 2021-08-17

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at changes in the DNA of tissue samples that were collected from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

microarray analysis

GENETIC

molecular genetic technique

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

diagnostic laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Guido Marcucci, MD · Ohio State University Comprehensive Cancer Center

Eligibility

Min Age
15 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898092 on ClinicalTrials.gov